Bionomics Limited Rings the Closing Bell

ABOUT THIS EVENT

Bionomics Limited (Nasdaq: BNOX), a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need, rings the Nasdaq Closing Bell remotely from across the globe.

Dr. Errol De Souza, Executive Chairman, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore